Previous Page  13 / 17 Next Page
Information
Show Menu
Previous Page 13 / 17 Next Page
Page Background

Page 51

conferenceseries

.com

Volume 8

Journal of Clinical & Experimental Pathology

Pathology Summit 2018

July 02-03, 2018

July 02-03, 2018 Bangkok, Thailand

15

th

Global Experts Meeting on

Pathology and Laboratory Medicine

Tumor infiltrating cytotoxic CD8 T-cells predict clinical outcome of neuroblastoma in children

Mahtab Rahbar

Iran University of Medical Sciences, Iran

N

euroblastoma is often infiltrated by inflammatory cells. One possible role of these inflammatory cells is that they

represent a cell-mediated immune response against cancer. CD8+ lymphocytes are a known crucial component of cell-

mediated immunity. This study was to explore the prognostic value of tumor-infiltrating CD8+ cytotoxic lymphocytes in

Neuroblastoma. Tumor-infiltrating CD8+ lymphocytes were assessed by immune-histochemical staining of tumor tissue from

36 neuroblastoma from April 2008 to May 2015. The number of CD8+ T-cells was counted in tumor nest (intra-tumoral) and

in the fibrovascular stroma of tumor (peritumoral) and their relationship with clinicopathologic outcome was determined.

The total number of CD8+ cells was inversely correlated with tumor histology grade (P<0.001), vascular invasion (P<0.001),

capsular invasion (P<0.002), calcification (P<0.005), necrosis of tumor (P<0.001), regional lymph nodes invasion (P<0.003),

distant metastasis (P<0.003), stage (P<0.003) and was positive correlated with N-myc oncogene presentation (P<0.002) in

neuroblastoma. However, there were no correlation between patient’s age, sex and size of tumor with infiltration of CD8+

cells (P<0.097, P<0.142 and P<0.722, respectively). In this analysis, total CD8 T-cell count was a dependent prognostic factor

in children. Total number and stromal CD8 lymphocytes were associated with better patient survival (P<0.003 and P<0.05,

respectively) in children. CD8 T lymphocytes have antitumor activity and influence the behavior of neuroblastoma and might

be potentially being exploited in the treatment of neuroblastoma.

rahbarahbar@gmail.com

J Clin Exp Pathol 2018, Volume 8

DOI: 10.4172/2161-0681-C2-049